Egetis Therapeutics AB Statistics
Total Valuation
STO:EGTX has a market cap or net worth of SEK 1.83 billion. The enterprise value is 1.78 billion.
| Market Cap | 1.83B |
| Enterprise Value | 1.78B |
Important Dates
The last earnings date was Tuesday, November 25, 2025.
| Earnings Date | Nov 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:EGTX has 395.16 million shares outstanding. The number of shares has increased by 22.32% in one year.
| Current Share Class | 395.16M |
| Shares Outstanding | 395.16M |
| Shares Change (YoY) | +22.32% |
| Shares Change (QoQ) | +1.20% |
| Owned by Insiders (%) | 10.25% |
| Owned by Institutions (%) | 18.63% |
| Float | 231.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 19.62 |
| PS Ratio | 33.06 |
| PB Ratio | 6.60 |
| P/TBV Ratio | 6.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.33 |
| EV / Sales | 32.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.75 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.33.
| Current Ratio | 0.80 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.40 |
| Interest Coverage | -20.55 |
Financial Efficiency
Return on equity (ROE) is -111.83% and return on invested capital (ROIC) is -49.43%.
| Return on Equity (ROE) | -111.83% |
| Return on Assets (ROA) | -33.74% |
| Return on Invested Capital (ROIC) | -49.43% |
| Return on Capital Employed (ROCE) | -91.03% |
| Revenue Per Employee | 1.39M |
| Profits Per Employee | -8.33M |
| Employee Count | 40 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 45.41 |
Taxes
In the past 12 months, STO:EGTX has paid 300,000 in taxes.
| Income Tax | 300,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.02% in the last 52 weeks. The beta is 1.26, so STO:EGTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -15.02% |
| 50-Day Moving Average | 5.62 |
| 200-Day Moving Average | 4.80 |
| Relative Strength Index (RSI) | 40.58 |
| Average Volume (20 Days) | 2,545,671 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:EGTX had revenue of SEK 55.40 million and -333.30 million in losses. Loss per share was -0.93.
| Revenue | 55.40M |
| Gross Profit | 16.80M |
| Operating Income | -316.50M |
| Pretax Income | -333.00M |
| Net Income | -333.30M |
| EBITDA | -291.03M |
| EBIT | -316.50M |
| Loss Per Share | -0.93 |
Balance Sheet
The company has 145.70 million in cash and 92.00 million in debt, giving a net cash position of 53.70 million or 0.14 per share.
| Cash & Cash Equivalents | 145.70M |
| Total Debt | 92.00M |
| Net Cash | 53.70M |
| Net Cash Per Share | 0.14 |
| Equity (Book Value) | 277.50M |
| Book Value Per Share | 0.77 |
| Working Capital | -49.10M |
Cash Flow
In the last 12 months, operating cash flow was -227.80 million and capital expenditures -1.50 million, giving a free cash flow of -229.30 million.
| Operating Cash Flow | -227.80M |
| Capital Expenditures | -1.50M |
| Free Cash Flow | -229.30M |
| FCF Per Share | -0.58 |
Margins
| Gross Margin | 30.32% |
| Operating Margin | -571.30% |
| Pretax Margin | -601.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:EGTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.32% |
| Shareholder Yield | -22.32% |
| Earnings Yield | -18.20% |
| FCF Yield | -12.52% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:EGTX has an Altman Z-Score of -2.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.75 |
| Piotroski F-Score | 2 |